Related Experiment Video
Updated: May 31, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Procalcitonin implication in renal cell apoptosis induced by acute pyelonephritis in children
Hafid Belhadj-Tahar1, Yvon Coulais, Mathieu Tafani
1Groupe Santé Recherche, Toulouse, France;
Insights
Procalcitonin (PCT) levels in children with acute pyelonephritis were studied. Lower PCT correlated with renal fibrosis, suggesting PCT may protect against kidney damage.
Area of Science:
- Biomedical research
- Pediatric nephrology
- Clinical trial
Background:
- Acute pyelonephritis is a common childhood kidney infection.
- Understanding the role of biomarkers like procalcitonin (PCT) in disease progression is crucial.
- Renal parenchyma apoptosis and fibrosis are significant complications of pyelonephritis.
Purpose of the Study:
- To investigate the physiological role of procalcitonin (PCT) in pediatric acute pyelonephritis.
- To determine the association between PCT levels and renal parenchyma apoptosis and fibrosis.
- To explore PCT's potential protective effects in kidney injury.
Main Methods:
- Prospective study of 183 children with acute pyelonephritis.
- Treatment included intravenous ceftriaxone and netilmicin, followed by tailored antibiotics.
- Serum PCT, C-reactive protein, and phospholipase A2 were measured. Renal scintigraphy ((99m)Tc-DMSA) was performed on day 4 and 9 months later.
Main Results:
- 78% of children showed renal parenchyma alterations on day 4; 30% developed renal fibrosis at 9 months.
- Paradoxically, lower PCT levels were observed in cases with renal fibrosis due to apoptosis (4.19 vs 7.59 μg/L).
- Increased PCT levels correlated with favorable outcomes (recovery: 7.55 vs aggravation: 3.34 μg/L).
Conclusions:
- Procalcitonin may have a protective role against apoptosis in acute pyelonephritis.
- PCT levels appear to be a significant indicator of disease progression and outcome.
- The findings suggest PCT down-regulates nitric oxide, potentially mitigating renal damage.
Abstract:
The aim of this biomedical trial was to clarify the physiological role of procalcitonin (PCT) in renal parenchyma apoptosis and fibrosis caused by acute childhood pyelonephritis. This prospective study enrolled 183 children. All children were treated with bi-therapy according to the French consensus on acute pyelonephritis treatment dated November 16, 1990: intra-vascular administration of ceftriaxone 50 mg/kg/day and netromicine 7 mg/kg/day during the first 48 hours, followed by specific antibiotherapy suited to antibiogram. On admission, PCT, C-reactive protein, and phospholipase A2 were quantified in serum. Scintigraphy monitoring with (99m)Tc-DMSA was performed on day 4 and 9 months later, in the presence of persistent abnormalities. On day 4, 78% presented renal parenchyma alterations and 30% renal fibrosis 9 months after admission. Paradoxically, PCT level was significantly lower in the presence of renal fibrosis due to cell apoptosis (4.19 vs 7.59 μgL(-1)). A significant increase in PCT indicated favorable progress (recovery 7.55 vs aggravation 3.34) and no difference between recovery and improvement. This result suggests the protective effect of PCT against apoptosis by nitric oxide down-regulation.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Pancreatitis II: Pathophysiology
